Protalix Biotherapeutics Inc. (PLX) at a glance

Protalix Biotherapeutics Inc. (PLX) is a micro-cap Healthcare company. It trades at $2.63, with a P/E of 10.4, a 23.5% profit margin and revenue growth of 27.1%. It does not pay a dividend. Vestovix scores it 77/100 overall. Its strongest dimension is Value (99/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$2.63

Market cap

$193.4M

P/E ratio

10.4

Dividend yield

None

Beta

0.01

52-week range

$1.52 to $3.19